Monte Rosa Therapeutics (GLUE) Non-Current Deferred Tax Liability (2024)

Monte Rosa Therapeutics' Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $11.5 million for Q4 2024.

• In Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $11.5 million; the TTM figure through Dec 2024 stood at $11.5 million (changed N/A YoY), while the FY2024 annual figure was $11.5 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability for Q4 2024 stood at $11.5 million.
• The five-year high for Non-Current Deferred Tax Liability was $11.5 million in Q4 2024, with the low at $11.5 million in Q4 2024.